Quinazolinone cholecystokinin-B receptor ligands.
Yu
M J
MJ
Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285.
Thrasher
K J
KJ
McCowan
J R
JR
Mason
N R
NR
Mendelsohn
L G
LG
D000818:Animals; D001921:Brain / Q000378:metabolism; D002462:Cell Membrane / Q000378:metabolism; D002766:Cholecystokinin / Q000031:analogs & derivatives* / Q000378:metabolism* / Q000494:pharmacology; D007700:Kinetics; D008024:Ligands; D051379:Mice; D015394:Molecular Structure; D011799:Quinazolines / Q000138:chemical synthesis* / Q000378:metabolism / Q000494:pharmacology; D011949:Receptors, Cholecystokinin / Q000187:drug effects / Q000378:metabolism*; D013329:Structure-Activity Relationship
D008024:Ligands; D011799:Quinazolines; D011949:Receptors, Cholecystokinin; D002766:Cholecystokinin